Home / Learn / Precision Medicine / Treatment / Immunotherapy / Archived IO Webinar Details

Webinar:MRD Clinical Updates in Chronic Lymphocytic Leukemia

This webinar provides the multidisciplinary cancer team with important and practical information for the assessment of measurable residual disease (MRD) as part of routine clinical practice for their patients with Chronic Lymphocytic Leukemia (CLL).

The presentation will be valuable for understanding the impact of MRD on treatment decisions and practice patterns, which has promise to lead to major improvements in outcomes for CLL patients in the very near future.

Faculty:

  • John M. Pagel, MD, PhD, Chief of Hematologic Malignancies; Director, Stem Cell Transplantation, Swedish Cancer Institute
  • Cecilia Arana Yi, MD, Senior Associate Consultant; Director of Leukemia Services, Hematology/Oncology, Department of Internal Medicine, Mayo Clinic
  • Amy Goodrich, RN, MSN, CRNP-AC, Research Associate, The Johns Hopkins School of Medicine; Nurse Practitioner, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University (Moderator)

Register

This project is supported by Adaptive Biotechnologies.